Pinar Gumus Balikcioglu is an Endocrinology/Metabolic physician affiliated with Duke University. OpenAlex indexes 31 publications with 400 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2018–2021 per NIH RePORTER. The latest:
- Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese Adolescents
Duke University
FY2021$187,891K23DK117067 - Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese Adolescents
Duke University
FY2021$93,946K23DK117067 - Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese Adolescents
Duke University
FY2020$187,944K23DK117067
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
Scott Antonia, MD
Duke University
Jonathan Piccini, MD
Duke University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”